ACM
TLSIW icon

Alpha Capital Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Alpha Capital Management’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,000
Closed -$18.7K – 120
2025
Q3 		$18.7K Sell
11,000
-11,222
-50% -$20.4K ﹤0.01% 117
2025
Q2 		$28.9K Hold
22,222
– – 0.01% 112
2025
Q1 		$25.8K Hold
22,222
– – ﹤0.01% 115
2024
Q4 		$24.4K Hold
22,222
– – ﹤0.01% 114
2024
Q3 		$22.4K Hold
22,222
– – ﹤0.01% 112
2024
Q2 		$33.3K Hold
22,222
– – 0.01% 115
2024
Q1 		$22.2K Buy
+22,222
New +$22.2K ﹤0.01% 116

Other funds holding TLSIW

Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Alpha Capital Management's TLSIW Position: Q4 2025 in Review

Alpha Capital Management sold out of TriSalus Life Sciences Warrant (TLSIW) in Q4 2025, closing a stake of 11,000 shares — an estimated $18.7K sold.

Alpha Capital Management first reported a position in TLSIW in Q1 2024 and held it in 7 quarters. The position peaked at $33.3K in Q2 2024. 8 funds tracked by Wall St. Rank hold TLSIW as of Q4 2025.

  • Alpha Capital Management reported no remaining TriSalus Life Sciences Warrant position as of Q4 2025 after selling out during the quarter.
  • Alpha Capital Management sold 11,000 TriSalus Life Sciences Warrant shares in Q4 2025, an estimated $18.7K.
  • Alpha Capital Management first reported a position in TriSalus Life Sciences Warrant in Q1 2024 and held it in 7 quarters.
  • Alpha Capital Management's TriSalus Life Sciences Warrant position peaked at $33.3K in Q2 2024.
  • 8 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q4 2025.

Based on Alpha Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.